Wells Fargo
INBX icon

Wells Fargo’s Inhibrx INBX Stock Holding History

Wells Fargo’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Sell
3,938
-6,875
-64% -$510K ﹤0.01% 4531
2025
Q4 		$854K Buy
10,813
+3,214
+42% +$219K ﹤0.01% 4090
2025
Q3 		$256K Buy
7,599
+1,133
+18% +$27.9K ﹤0.01% 4789
2025
Q2 		$92.3K Sell
6,466
-315
-5% -$4.07K ﹤0.01% 5242
2025
Q1 		$94.9K Buy
6,781
+134
+2% +$1.82K ﹤0.01% 5125
2024
Q4 		$102K Buy
6,647
+1,695
+34% +$25.8K ﹤0.01% 5193
2024
Q3 		$77.5K Buy
4,952
+431
+10% +$6.06K ﹤0.01% 5160
2024
Q2 		$64.1K Buy
+4,521
New +$70.6K ﹤0.01% 5190

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo's INBX Position: Q1 2026 in Review

Wells Fargo reduced its Inhibrx (INBX) stake by 64% in Q1 2026, selling an estimated $510K and leaving 3,938 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #4531.

Wells Fargo first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $854K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Wells Fargo held 3,938 shares of Inhibrx worth $265K as of Q1 2026.
  • Wells Fargo sold 6,875 Inhibrx shares in Q1 2026, an estimated $510K.
  • Inhibrx made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4531 holding.
  • Wells Fargo first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Wells Fargo's Inhibrx position peaked at $854K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.